Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 49 entries
Sorted by: Best Match Show Resources per page
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy.

NPJ breast cancer

Stemmer SM, Steiner M, Rizel S, Ben-Baruch N, Uziely B, Jakubowski DM, Baron J, Shak S, Soussan-Gutman L, Bareket-Samish A, Fried G, Rosengarten O, Itay A, Nisenbaum B, Katz D, Leviov M, Tokar M, Liebermann N, Geffen DB.
PMID: 31728408
NPJ Breast Cancer. 2019 Nov 08;5:41. doi: 10.1038/s41523-019-0137-3. eCollection 2019.

The 21-gene Recurrence Score (RS) assay is a validated prognosticator/predictor of chemotherapy (CT) benefit in early-stage estrogen receptor (ER)-positive breast cancer (BC). Long-term data from real-life clinical practice where treatment was guided by the RS result are lacking. We...

Cite
Stemmer SM, Steiner M, Rizel S, et al. Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ Breast Cancer. 2019;5:41doi: 10.1038/s41523-019-0137-3.
Stemmer, S. M., Steiner, M., Rizel, S., Ben-Baruch, N., Uziely, B., Jakubowski, D. M., Baron, J., Shak, S., Soussan-Gutman, L., Bareket-Samish, A., Fried, G., Rosengarten, O., Itay, A., Nisenbaum, B., Katz, D., Leviov, M., Tokar, M., Liebermann, N., & Geffen, D. B. (2019). Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ breast cancer, 541. https://doi.org/10.1038/s41523-019-0137-3
Stemmer, Salomon M, et al. "Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy." NPJ breast cancer vol. 5 (2019): 41. doi: https://doi.org/10.1038/s41523-019-0137-3
Stemmer SM, Steiner M, Rizel S, Ben-Baruch N, Uziely B, Jakubowski DM, Baron J, Shak S, Soussan-Gutman L, Bareket-Samish A, Fried G, Rosengarten O, Itay A, Nisenbaum B, Katz D, Leviov M, Tokar M, Liebermann N, Geffen DB. Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy. NPJ Breast Cancer. 2019 Nov 08;5:41. doi: 10.1038/s41523-019-0137-3. eCollection 2019. PMID: 31728408; PMCID: PMC6841708.
Copy Download .nbib Format: NLM
Prevalence of SARS-CoV-2 infection among people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic.

Canadian journal of public health = Revue canadienne de sante publique

Luong L, Beder M, Nisenbaum R, Orkin A, Wong J, Damba C, Emond R, Lena S, Wright V, Loutfy M, Bruce-Barrett C, Cheung W, Cheung YK, Williams V, Vanmeurs M, Boozary A, Manning H, Hester J, Hwang SW.
PMID: 34919211
Can J Public Health. 2021 Dec 17; doi: 10.17269/s41997-021-00591-8. Epub 2021 Dec 17.

OBJECTIVES: People experiencing homelessness are at increased risk of SARS-CoV-2 infection. This study reports the point prevalence of SARS-CoV-2 infection during testing conducted at sites serving people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic....

Cite
Luong L, Beder M, Nisenbaum R, et al. Prevalence of SARS-CoV-2 infection among people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic. Can J Public Health. 2021;doi: 10.17269/s41997-021-00591-8.
Luong, L., Beder, M., Nisenbaum, R., Orkin, A., Wong, J., Damba, C., Emond, R., Lena, S., Wright, V., Loutfy, M., Bruce-Barrett, C., Cheung, W., Cheung, Y. K., Williams, V., Vanmeurs, M., Boozary, A., Manning, H., Hester, J., & Hwang, S. W. (2021). Prevalence of SARS-CoV-2 infection among people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic. Canadian journal of public health = Revue canadienne de sante publique, . https://doi.org/10.17269/s41997-021-00591-8
Luong, Linh, et al. "Prevalence of SARS-CoV-2 infection among people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic." Canadian journal of public health = Revue canadienne de sante publique vol. (2021). doi: https://doi.org/10.17269/s41997-021-00591-8
Luong L, Beder M, Nisenbaum R, Orkin A, Wong J, Damba C, Emond R, Lena S, Wright V, Loutfy M, Bruce-Barrett C, Cheung W, Cheung YK, Williams V, Vanmeurs M, Boozary A, Manning H, Hester J, Hwang SW. Prevalence of SARS-CoV-2 infection among people experiencing homelessness in Toronto during the first wave of the COVID-19 pandemic. Can J Public Health. 2021 Dec 17; doi: 10.17269/s41997-021-00591-8. Epub 2021 Dec 17. PMID: 34919211.
Copy Download .nbib Format: NLM
The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer.

Breast (Edinburgh, Scotland)

Bar Y, Bar K, Itzhak I, Niselbaum CS, Dershowitz N, Shachar E, Weiss-Meilik A, Golan O, Wolf I, Menes T, Sonnenblick A.
PMID: 34509707
Breast. 2021 Dec;60:78-85. doi: 10.1016/j.breast.2021.09.002. Epub 2021 Sep 04.

BACKGROUND: Symptomatic breast cancers share aggressive clinico-pathological characteristics compared to screen-detected breast cancers. We assessed the association between the method of cancer detection and genomic and clinical risk, and its effect on adjuvant chemotherapy recommendations.PATIENTS AND METHODS: Patients with...

Cite
Bar Y, Bar K, Itzhak I, et al. The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer. Breast. 2021;60:78-85doi: 10.1016/j.breast.2021.09.002.
Bar, Y., Bar, K., Itzhak, I., Niselbaum, C. S., Dershowitz, N., Shachar, E., Weiss-Meilik, A., Golan, O., Wolf, I., Menes, T., & Sonnenblick, A. (2021). The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer. Breast (Edinburgh, Scotland), 6078-85. https://doi.org/10.1016/j.breast.2021.09.002
Bar, Yael, et al. "The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer." Breast (Edinburgh, Scotland) vol. 60 (2021): 78-85. doi: https://doi.org/10.1016/j.breast.2021.09.002
Bar Y, Bar K, Itzhak I, Niselbaum CS, Dershowitz N, Shachar E, Weiss-Meilik A, Golan O, Wolf I, Menes T, Sonnenblick A. The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer. Breast. 2021 Dec;60:78-85. doi: 10.1016/j.breast.2021.09.002. Epub 2021 Sep 04. PMID: 34509707; PMCID: PMC8437822.
Copy Download .nbib Format: NLM
Clinical Presentation and Outcome of Patients Experiencing Homelessness Presenting With ST-Segment Elevation Myocardial Infarction.

The Canadian journal of cardiology

Liauw SSL, Luong L, Liu S, Atcha M, Kwok Y, Nisenbaum R, Fam N, Hwang SW, Cheema AN.
PMID: 34004281
Can J Cardiol. 2021 Oct;37(10):1555-1561. doi: 10.1016/j.cjca.2021.05.003. Epub 2021 May 15.

BACKGROUND: Cardiovascular disease remains a major cause of morbidity and mortality among homeless adults. Despite major advances in the management of ST elevation myocardial infarction (STEMI), limited information is available for the clinical presentation and management and outcome of...

Cite
Liauw SSL, Luong L, Liu S, et al. Clinical Presentation and Outcome of Patients Experiencing Homelessness Presenting With ST-Segment Elevation Myocardial Infarction. Can J Cardiol. 2021;37(10):1555-1561doi: 10.1016/j.cjca.2021.05.003.
Liauw, S. S. L., Luong, L., Liu, S., Atcha, M., Kwok, Y., Nisenbaum, R., Fam, N., Hwang, S. W., & Cheema, A. N. (2021). Clinical Presentation and Outcome of Patients Experiencing Homelessness Presenting With ST-Segment Elevation Myocardial Infarction. The Canadian journal of cardiology, 37(10), 1555-1561. https://doi.org/10.1016/j.cjca.2021.05.003
Liauw, Samantha S L, et al. "Clinical Presentation and Outcome of Patients Experiencing Homelessness Presenting With ST-Segment Elevation Myocardial Infarction." The Canadian journal of cardiology vol. 37,10 (2021): 1555-1561. doi: https://doi.org/10.1016/j.cjca.2021.05.003
Liauw SSL, Luong L, Liu S, Atcha M, Kwok Y, Nisenbaum R, Fam N, Hwang SW, Cheema AN. Clinical Presentation and Outcome of Patients Experiencing Homelessness Presenting With ST-Segment Elevation Myocardial Infarction. Can J Cardiol. 2021 Oct;37(10):1555-1561. doi: 10.1016/j.cjca.2021.05.003. Epub 2021 May 15. PMID: 34004281.
Copy Download .nbib Format: NLM
Cognitive determinants of community functioning and quality of life in homeless adults with mental illness: 6-year follow-up from the At Home/Chez Soi Study Toronto site.

Psychological medicine

Gicas KM, Mejia-Lancheros C, Nisenbaum R, Wang R, Hwang SW, Stergiopoulos V.
PMID: 33926584
Psychol Med. 2021 Apr 30;1-9. doi: 10.1017/S0033291721001550. Epub 2021 Apr 30.

BACKGROUND: High rates of physical and mental health comorbidities are associated with functional impairment among persons who are homeless. Cognitive dysfunction is common, but how it contributes to various functional outcomes in this population has not been well investigated....

Cite
Gicas KM, Mejia-Lancheros C, Nisenbaum R, et al. Cognitive determinants of community functioning and quality of life in homeless adults with mental illness: 6-year follow-up from the At Home/Chez Soi Study Toronto site. Psychol Med. 2021;1-9doi: 10.1017/S0033291721001550.
Gicas, K. M., Mejia-Lancheros, C., Nisenbaum, R., Wang, R., Hwang, S. W., & Stergiopoulos, V. (2021). Cognitive determinants of community functioning and quality of life in homeless adults with mental illness: 6-year follow-up from the At Home/Chez Soi Study Toronto site. Psychological medicine, 1-9. https://doi.org/10.1017/S0033291721001550
Gicas, K M, et al. "Cognitive determinants of community functioning and quality of life in homeless adults with mental illness: 6-year follow-up from the At Home/Chez Soi Study Toronto site." Psychological medicine vol. (2021): 1-9. doi: https://doi.org/10.1017/S0033291721001550
Gicas KM, Mejia-Lancheros C, Nisenbaum R, Wang R, Hwang SW, Stergiopoulos V. Cognitive determinants of community functioning and quality of life in homeless adults with mental illness: 6-year follow-up from the At Home/Chez Soi Study Toronto site. Psychol Med. 2021 Apr 30;1-9. doi: 10.1017/S0033291721001550. Epub 2021 Apr 30. PMID: 33926584.
Copy Download .nbib Format: NLM
Challenges in Cross-Cultural Communication in Breast Cancer Surgery: Is there a Gender Gap?.

Journal of cancer education : the official journal of the American Association for Cancer Education

Hu SY, Reel E, Nisenbaum R, Scheer AS.
PMID: 33506410
J Cancer Educ. 2021 Jan 27; doi: 10.1007/s13187-020-01939-3. Epub 2021 Jan 27.

The aim of this study is to identify [1] facilitators and barriers to cross-cultural communication with Canadian immigrants during the breast cancer (BC) surgical consultation and [2] the impact of cultural sensitivity training on the perception of cross-cultural communication...

Cite
Hu SY, Reel E, Nisenbaum R, et al. Challenges in Cross-Cultural Communication in Breast Cancer Surgery: Is there a Gender Gap?. J Cancer Educ. 2021;doi: 10.1007/s13187-020-01939-3.
Hu, S. Y., Reel, E., Nisenbaum, R., & Scheer, A. S. (2021). Challenges in Cross-Cultural Communication in Breast Cancer Surgery: Is there a Gender Gap?. Journal of cancer education : the official journal of the American Association for Cancer Education, . https://doi.org/10.1007/s13187-020-01939-3
Hu, Shu Yang, et al. "Challenges in Cross-Cultural Communication in Breast Cancer Surgery: Is there a Gender Gap?." Journal of cancer education : the official journal of the American Association for Cancer Education vol. (2021). doi: https://doi.org/10.1007/s13187-020-01939-3
Hu SY, Reel E, Nisenbaum R, Scheer AS. Challenges in Cross-Cultural Communication in Breast Cancer Surgery: Is there a Gender Gap?. J Cancer Educ. 2021 Jan 27; doi: 10.1007/s13187-020-01939-3. Epub 2021 Jan 27. PMID: 33506410.
Copy Download .nbib Format: NLM
The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer.

Breast (Edinburgh, Scotland)

Bar Y, Bar K, Itzhak I, Niselbaum CS, Dershowitz N, Shachar E, Weiss-Meilik A, Golan O, Wolf I, Menes T, Sonnenblick A.
PMID: 34509707
Breast. 2021 Sep 04;60:78-85. doi: 10.1016/j.breast.2021.09.002. Epub 2021 Sep 04.

BACKGROUND: Symptomatic breast cancers share aggressive clinico-pathological characteristics compared to screen-detected breast cancers. We assessed the association between the method of cancer detection and genomic and clinical risk, and its effect on adjuvant chemotherapy recommendations.PATIENTS AND METHODS: Patients with...

Cite
Bar Y, Bar K, Itzhak I, et al. The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer. Breast. 2021;60:78-85doi: 10.1016/j.breast.2021.09.002.
Bar, Y., Bar, K., Itzhak, I., Niselbaum, C. S., Dershowitz, N., Shachar, E., Weiss-Meilik, A., Golan, O., Wolf, I., Menes, T., & Sonnenblick, A. (2021). The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer. Breast (Edinburgh, Scotland), 6078-85. https://doi.org/10.1016/j.breast.2021.09.002
Bar, Yael, et al. "The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer." Breast (Edinburgh, Scotland) vol. 60 (2021): 78-85. doi: https://doi.org/10.1016/j.breast.2021.09.002
Bar Y, Bar K, Itzhak I, Niselbaum CS, Dershowitz N, Shachar E, Weiss-Meilik A, Golan O, Wolf I, Menes T, Sonnenblick A. The impact of tumor detection method on genomic and clinical risk and chemotherapy recommendation in early hormone receptor positive breast cancer. Breast. 2021 Sep 04;60:78-85. doi: 10.1016/j.breast.2021.09.002. Epub 2021 Sep 04. PMID: 34509707; PMCID: PMC8437822.
Copy Download .nbib Format: NLM
Correction: Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice.

PloS one

Peron JP, de Brito AA, Pelatti M, Brandão WN, Vitoretti LB, Greiffo FR, da Silveira EC, Oliveira-Junior MC, Maluf M, Evangelista L, Halpern S, Nisenbaum MG, Perin P, Czeresnia CE, Câmara NO, Aimbire F, de Paula Vieira R, Zatz M, de Oliveira AP.
PMID: 26406994
PLoS One. 2015 Sep 25;10(9):e0139294. doi: 10.1371/journal.pone.0139294. eCollection 2015.

No abstract available.

Cite
Peron JP, de Brito AA, Pelatti M, et al. Correction: Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice. PLoS One. 2015;10(9):e0139294doi: 10.1371/journal.pone.0139294.
Peron, J. P., de Brito, A. A., Pelatti, M., Brandão, W. N., Vitoretti, L. B., Greiffo, F. R., da Silveira, E. C., Oliveira-Junior, M. C., Maluf, M., Evangelista, L., Halpern, S., Nisenbaum, M. G., Perin, P., Czeresnia, C. E., Câmara, N. O., Aimbire, F., de Paula Vieira, R., Zatz, M., & de Oliveira, A. P. (2015). Correction: Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice. PloS one, 10(9), e0139294. https://doi.org/10.1371/journal.pone.0139294
Peron, Jean Pierre Schatzmann, et al. "Correction: Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice." PloS one vol. 10,9 (2015): e0139294. doi: https://doi.org/10.1371/journal.pone.0139294
Peron JP, de Brito AA, Pelatti M, Brandão WN, Vitoretti LB, Greiffo FR, da Silveira EC, Oliveira-Junior MC, Maluf M, Evangelista L, Halpern S, Nisenbaum MG, Perin P, Czeresnia CE, Câmara NO, Aimbire F, de Paula Vieira R, Zatz M, de Oliveira AP. Correction: Human Tubal-Derived Mesenchymal Stromal Cells Associated with Low Level Laser Therapy Significantly Reduces Cigarette Smoke-Induced COPD in C57BL/6 mice. PLoS One. 2015 Sep 25;10(9):e0139294. doi: 10.1371/journal.pone.0139294. eCollection 2015. PMID: 26406994; PMCID: PMC4583288.
Copy Download .nbib Format: NLM
Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates.

Molecular neuropsychiatry

Martin MV, Mirnics K, Nisenbaum LK, Vawter MP.
PMID: 26405684
Mol Neuropsychiatry. 2015 Jul;1(2):82-93. doi: 10.1159/000430786.

The NMDA receptor antagonist phencyclidine (PCP) creates schizophrenia-like symptoms in normal controls. The effect of PCP on non-human primate brain gene expression was examined and compared to changes induced by olanzapine treatment. Experimental studies of PCP and antipsychotic drugs...

Cite
Martin MV, Mirnics K, Nisenbaum LK, et al. Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates. Mol Neuropsychiatry. 2015;1(2):82-93doi: 10.1159/000430786.
Martin, M. V., Mirnics, K., Nisenbaum, L. K., & Vawter, M. P. (2015). Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates. Molecular neuropsychiatry, 1(2), 82-93. https://doi.org/10.1159/000430786
Martin, Maureen V, et al. "Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates." Molecular neuropsychiatry vol. 1,2 (2015): 82-93. doi: https://doi.org/10.1159/000430786
Martin MV, Mirnics K, Nisenbaum LK, Vawter MP. Olanzapine Reversed Brain Gene Expression Changes Induced by Phencyclidine Treatment in Non-Human Primates. Mol Neuropsychiatry. 2015 Jul;1(2):82-93. doi: 10.1159/000430786. PMID: 26405684; PMCID: PMC4578732.
Copy Download .nbib Format: NLM
Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study.

medRxiv : the preprint server for health sciences

Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q, Zeng H, Nisenbaum EJ, Liu L, Zhao Y, Zhang D, Levine CG, Cejas I, Dai Q, Zeng M, Herman P, Jourdaine C, de With K, Draf J, Chen B, Jayaweera DT, Denneny JC, Casiano R, Yu H, Eshraghi AA, Hummel T, Liu X, Shu Y, Lu H.
PMID: 32511546
medRxiv. 2020 May 16; doi: 10.1101/2020.05.13.20100198.

OBJECTIVE: Evaluate the prevalence and characteristics of olfactory or gustatory dysfunction in COVID-19 patients Study Design: Multicenter Case Series Setting: 5 tertiary care hospitals (3 in China, 1 in France, 1 in Germany) Subjects and Methods: 394 PCR confirmed...

Cite
Qiu C, Cui C, Hautefort C, et al. Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study. medRxiv. 2020;doi: 10.1101/2020.05.13.20100198.
Qiu, C., Cui, C., Hautefort, C., Haehner, A., Zhao, J., Yao, Q., Zeng, H., Nisenbaum, E. J., Liu, L., Zhao, Y., Zhang, D., Levine, C. G., Cejas, I., Dai, Q., Zeng, M., Herman, P., Jourdaine, C., de With, K., Draf, J., Chen, B., Jayaweera, D. T., Denneny, J. C., Casiano, R., Yu, H., Eshraghi, A. A., Hummel, T., Liu, X., Shu, Y., & Lu, H. (2020). Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2020.05.13.20100198
Qiu, Chenghao, et al. "Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study." medRxiv : the preprint server for health sciences vol. (2020). doi: https://doi.org/10.1101/2020.05.13.20100198
Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q, Zeng H, Nisenbaum EJ, Liu L, Zhao Y, Zhang D, Levine CG, Cejas I, Dai Q, Zeng M, Herman P, Jourdaine C, de With K, Draf J, Chen B, Jayaweera DT, Denneny JC, Casiano R, Yu H, Eshraghi AA, Hummel T, Liu X, Shu Y, Lu H. Olfactory and Gustatory Dysfunction as An Early Identifier of COVID-19 in Adults and Children: An International Multicenter Study. medRxiv. 2020 May 16; doi: 10.1101/2020.05.13.20100198. PMID: 32511546; PMCID: PMC7274227.
Copy Download .nbib Format: NLM
The Effect of Housing First on Housing Stability for People with Mental Illness and Low Intellectual Functioning.

Canadian journal of psychiatry. Revue canadienne de psychiatrie

Durbin A, Lunsky Y, Wang R, Nisenbaum R, Hwang SW, O'Campo P, Stergiopoulos V.
PMID: 29916270
Can J Psychiatry. 2018 Jan 01;706743718782940. doi: 10.1177/0706743718782940. Epub 2018 Jan 01.

OBJECTIVE: Housing First (HF) has been linked to increased tenure in housing for homeless people with mental illness, but the effect of HF on housing stability for people with borderline or lower intellectual functioning has not been examined. This...

Cite
Durbin A, Lunsky Y, Wang R, et al. The Effect of Housing First on Housing Stability for People with Mental Illness and Low Intellectual Functioning. Can J Psychiatry. 2018;706743718782940doi: 10.1177/0706743718782940.
Durbin, A., Lunsky, Y., Wang, R., Nisenbaum, R., Hwang, S. W., O'Campo, P., & Stergiopoulos, V. (2018). The Effect of Housing First on Housing Stability for People with Mental Illness and Low Intellectual Functioning. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 706743718782940. https://doi.org/10.1177/0706743718782940
Durbin, Anna, et al. "The Effect of Housing First on Housing Stability for People with Mental Illness and Low Intellectual Functioning." Canadian journal of psychiatry. Revue canadienne de psychiatrie vol. (2018): 706743718782940. doi: https://doi.org/10.1177/0706743718782940
Durbin A, Lunsky Y, Wang R, Nisenbaum R, Hwang SW, O'Campo P, Stergiopoulos V. The Effect of Housing First on Housing Stability for People with Mental Illness and Low Intellectual Functioning. Can J Psychiatry. 2018 Jan 01;706743718782940. doi: 10.1177/0706743718782940. Epub 2018 Jan 01. PMID: 29916270; PMCID: PMC6299190.
Copy Download .nbib Format: NLM
Routinely asking patients about income in primary care: a mixed-methods study.

BJGP open

Pinto AD, Shenfeld E, Aratangy T, Wang R, Nisenbaum R, Lofters A, Bloch G, Kiran T.
PMID: 34666982
BJGP Open. 2021 Oct 19; doi: 10.3399/BJGPO.2021.0090. Epub 2021 Oct 19.

BACKGROUND: Income is a key social determinant of health yet it is rare for data on income to be routinely collected and integrated with electronic health records.AIM: To examine response bias and evaluate patient perspectives of being asked about...

Cite
Pinto AD, Shenfeld E, Aratangy T, et al. Routinely asking patients about income in primary care: a mixed-methods study. BJGP Open. 2021;doi: 10.3399/BJGPO.2021.0090.
Pinto, A. D., Shenfeld, E., Aratangy, T., Wang, R., Nisenbaum, R., Lofters, A., Bloch, G., & Kiran, T. (2021). Routinely asking patients about income in primary care: a mixed-methods study. BJGP open, . https://doi.org/10.3399/BJGPO.2021.0090
Pinto, Andrew David, et al. "Routinely asking patients about income in primary care: a mixed-methods study." BJGP open vol. (2021). doi: https://doi.org/10.3399/BJGPO.2021.0090
Pinto AD, Shenfeld E, Aratangy T, Wang R, Nisenbaum R, Lofters A, Bloch G, Kiran T. Routinely asking patients about income in primary care: a mixed-methods study. BJGP Open. 2021 Oct 19; doi: 10.3399/BJGPO.2021.0090. Epub 2021 Oct 19. PMID: 34666982.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 49 entries